American Diabetes Association (ADA), (2012) “Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, Vol. 35, Suppl. 1, 2012, pp. S64-S69.
Asif, N.; Hassan, K.; Mahmud, S.; Abbass Zaheer, H.; Naseem, L.; Zafar, T. and Shams, R. (2007) “Comparison of serum ferritin levels in three trimesters of pregnancy and their correlation with increasing gravidity.” International Journal of Pathology 5, 26-30.
Bar J, Harell D, Bardin R, Pardo J, Chen R, Hod M, Sullivan M. (2002), “The elevated plasma lipoprotein(a) concentrations in pre-eclampsia do not precede the development of the disorder.” Thrombosis Res 2002; 105: 19-23. 203.
Barqi, A. (2011) “Nutritional status and some biochemical and healthy indexes in Sulaimania.” .Centers for Disease Control and Prevention (CDC), (2014), “1600 Clifton Road Atlanta”, GA 30329-4027, USA
Centre for Disease Control and Prevention (CDC), (2005) “Use of supplements containing folic acid among women child beareu age. United states,” 2005.
Crane, JM.; White, J.; Murphy, P.; Burrage, L.; Hutchens, D. (2009), “The effect of gestational weight gain by body mass index on maternal and neonatal outcomes.” J Obstet Gynaecol Can. 2009;31(1):28-35.
Douglas, J.; Gary, R.; Reid, E and Stephan L. (1984) “ FERENE: A new spectrophotometric reagent for iron .” CAN J.Chem.62p . 721-724.
Fahraeus, L.; Larsson – Cohn, U. and Wallentin, L. (1995) “Plasma lipoproteins including high density lipoprotein subfractions during normal pregnancy.”Obstet. Gynecol 66:468 – 472.
Frederick, IO.; Williams, MA.; Sales, AE.; Martin, DP. and Killien, M. (2008) “Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight”. Matern Child Health J. 2008;12(5):557-67.
Friedwald, W.; Levy, P. and Fredrickson, D. (1972) “Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuge.” Clin Chem 1972; 18:499-502.
Garn, S.; Keating, M. and Falkner, F. (1981)a “Hematological status and pregnancy outcomes,” The American Journal of Clinical Nutrition, vol. 34, no. 1, pp. 115–117, 1981.
Ichipi-Ifukor, P.; Juliet, J.; Rita, N. and Oberhiri L. (2013) “Changes in Haematological Indices in Normal Pregnancy” Hindawi Publishing Corporation Physiology Journal Volume 2013, Article ID 283814, 4 pages http://dx.doi.org/10.1155/2013/283814.
Jimenez, D. ; Pocovi, M. and Ramon, C. (1988) “Longitudinal Study of Plasma Lipids and Lipoprotein Cholesterol in Normal Pregnancy and Puerperium” Invest.
James, T. ; Reid, H. and Mullings A. (2008) “Are published standards for haematological indices in pregnancy applicable across populations: an evaluation in healthy pregnant Jamaican women,” BMC Pregnancy and Childbirth, vol. 8, article 8, 2008.
Lorentsen, B. and Henriksen, T. (1998), Plasma lipids and vascular dysfunction in pre-eclampsia. Semin Reprod. Endocrinol. 1998; 16: 33-39.
Liu, A. and Lawn, R. (1995), “Vascular interactions of lipoprotein (a).” Curr Opin Lipidol 1995; 5:269–73.
Ministério, d. (2005) Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas. Área Técnica de Saúde da Mulher. Pré-natal e puerpério: atenção qualificada e humanizada - manual técnico. Brasília: Ministério da Saúde; 2005.
Nazli, B. (2010) “Lipid metabolism study in women of pregnancy induced hypertension cases” , Ph.D THESIS, University of Peshawar ;NWFP- Pakistan
Osonuga, I. ; Osonuga, O.; Onadeko, A. ; Osonuga, A. and Osonuga A., (2011) “Hematological profile of pregnant women in southwest of Nigeria,” Asian Pacific Journal of Tropical Disease , vol. 1, no. 3, pp. 232–234, 2011.
Potter, J. and Neste, P. (1979) “The hyperlipidemia of pregnancy in normal and complicated pregnancies.” Am. J. Obstet. Gynecol. 1979, 133; 165- 179.
Sattar, N.; Bendomir, A.; Berry, C.; Shepherd, J.; Greer, IA. an Packard, CJ. (1997) “ Lipoprotein subfraction concentrations in Pre-eclampsia: pathogenic parallels to atherosclerosis.” Obstet Gynecol 1997; 89:403-8.
Seely, EW. and Solomon, CG. (2003) “ Insulin resistance and its potential role in pregnancy induced hypertension.” J. Clin. Endocrinol. Metab.
Shaw, J.; Dey, S.; Critchley, H. and Horne, A. (2010) “Current knowledge of the aetiology of human tubal ectopic pregnancy,” Human Reproduction Update, vol. 16, no. 4, Article ID dmp057, pp. 432–444, 2010.
Stock, M. and Metcalfe, J. (1994) “Maternal physiology during gestation. In: Knobil, E. and Neil, J. D. (eds): The physiology of reproduction. Raven press, New York. 1994, Pp. 947 – 983.
Turpin, C.; Ahenkorah, L.; Owiredu, W.; Laing, E. and Amidu, N. (2008) “The prevalence of the metabolic syndrome among Ghanaian pregnancy induced hypertensive patients using the World health Organisation and the national Cholesterol Education Program III criteria.” J. Med. Sci. 2008; 8: 443-451.
Victoria, P.; Otilia, D.; Palamaru, I.; Adam, C.; Nicoleta, F. and Doina, D. ( 2001) “MATERNAL HAEMATOLOGICAL AND BIOCHEMICAL PARAMETERS AND PREGNANCY OUTCOME”. The journal of preventive medicine. , 2001; 9(3): 27-33.
Wahed, F.; Latif, M. and Mahmud, M. (2008) “Fact of low hemoglobin and packed cell volume in pregnant women are at a stand still,” MymensinghMedical Journal, vol. 17, no. 1, pp. 4–7.
Wald, N. and Guckle, H. (1988) “Impact of Lipid Profile on Pregnancy Outcome in Urban Population”. Br. Med. J. , 297: 883 – 887.
WHO (2002) " Essential Antenatal, Perinatal and Postpartum Care". Regional Office for Europe, WHO,2002.
WHO (2004) “Prevention and treatment of malaria during pregnancy,” 2004, http://pdf.usaid.gov/pdf docs/Pnada621.pdf.
WHO (2001) “Iron deficiency anemia: a assessment, prevention and control”. United Nations Children’s Fund, United Nation University. A guide for programme managers. Geneva: WHO, 2001.
WHO (2005); World Health Organization . Food & Nutrition .Clinical & Universal Book. Academia International 2th ed .ISBN:9953-3-0082-8.
Zhao Y, Tang H, Liu S. (2000), “Serum lipoprotein (a) in woman with pregnancy induced hypertension.” Zhonghua Fu Chan Ke Za Zhi. 2000;35:145-7.